Search Results - "Moreno Nogueira, J. A."

Gemcitabine in Combination With Doxorubicin in Advanced Breast Cancer: Final Results of a Phase II Pharmacokinetic Trial by Pérez-Manga, G, Lluch, A, Alba, E, Moreno-Nogueira, J A, Palomero, M, García-Conde, J, Khayat, D, Rivelles, N

“…Gemcitabine has promising single-agent activity in advanced breast disease. The aim of this phase II study was to determine the efficacy, toxicity, and…”
Get full text

Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain by González-Larriba, J.L, Serrano, S, Alvarez-Mon, M, Camacho, F, Casado, M.A, Dı́az-Pérez, J.L, Dı́az-Rubio, E, Fosbrook, L, Guillem, V, López-López, J.J, Moreno-Nogueira, J.A, Toribio, J

“…In the randomised clinical trial E1684, the administration of interferon (IFN) alpha-2b resulted in prolonged disease-free and overall survival in high-risk…”
Get full text

Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists by Camps-Herrero, C., Paz-Ares, L., Codes, M., López-López, R., Antón-Torres, A., Gascón-Vilaplana, P., Guillem-Porta, V., Carrato, A., Cruz-Hernández, J. J., Caballero-Díaz, C., Blasco-Cordellat, A., Moreno-Nogueira, J. A., Díaz-Rubio, E.

“…Purpose The economic situation showed that the resources devoted to health spending are limited, making rationalisation of their consumption necessary. The…”
Get full text

Oncological translational research in the Spanish national health system: the INTRO study by Caballero, C., Jantus-Lewintre, E., Carrato, A., García-Foncillas, J., Gascón, P., Blasco, A., Moreno-Nogueira, J. A., Guillem, V., López, R., Codes, M., Antón, A., Díaz-Rubio, E., Camps, C.

“…Objectives Under the auspices of the Foundation for Excellence and Quality in Oncology (ECO), the Translational Research in Oncology Medical Services Study…”
Get full text

Adjuvant Treatment of Melanoma by Moreno Nogueira, J. A., Valero Arbizu, M., Pérez Temprano, R.

“…Melanomas represent 4% of all malignant tumors of the skin, yet account for 80% of deaths from skin cancer.While in the early stages patients can be…”
Get full text

Treatment of indolent non-Hodgkin's lymphomas by Moreno Nogueira, J A, Casas Fernández de Tejerina, A, Moreno Rey, C

“…Non-Hodgkin's Lymphomas (NHLs) are a heterogeneous group of entities with different pathologies. A total of 80% of these lymphomas are B-cell origin and only…”
Get more information

Treatment of aggressive non-Hodgkin's lymphomas by Moreno Nogueira, J A, Ruiz Borrego, M, Pérez Valderrama, B, Valero Azbiru, M

“…Aggressive non-Hodgkin's lymphomas (NHL) in localized stages I and II, without bulky areas and a fair International Prognostic Factor (IPI) (30% of all cases)…”
Get more information

Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas by Bezwoda, W., Rastogi, R.B., Erazo Valla, A., Diaz-Maqueo, J.C., Pavlovsky, S., Morioka, H., Resegotti, L., Rueckle, H., Somoza, N., Moreno-Nogueira, J.A., Bernasconi, C., Ho, A., Burns, I., Lardinois, J., van der Merwe, A., Richards, E.

“…59 previously untreated patients with intermediate- or high-grade, stage II–IV non-Hodgkin's lymphoma (NHL) were entered into an open-label, randomised,…”
Get full text

Randomized open label phase II study of pegilated liposomal doxorubicine (PLD) four or six-week scheduled in metastatic breast cancer (MBC) patients (p) by Ruiz, M., Bayo, J. L., Moreno Nogueira, J. A., Dorta, J., Casas, A. M., Morales, M.

“…Abstract only 10751 Background: PLD has the advantage of delivering the active anthracycline directly to the tumour site, provide comparable efficacy to…”
Get full text

Biweekly administration of irinotecan (CPT-11), oxaliplatin (OX) and 5-fluorouracil (5-FU) as first-line treatment of advanced or metastatic colorectal cancer (MCRC) by Reina, J. J., Sánchez-Rovira, P., Bernabé, R., Bolaños, M., González, E., Belón, J., Gómez-Reina, M. J., Gallurt, P., Moreno-Nogueira, J. A.

“…Abstract only…”
Get full text

Biweekly administration of irinotecan (CPT-11), oxaliplatin (OX) and 5-fluorouracil (5-FU) as first-line treatment of advanced or metastatic colorectal cancer (MCRC) by Reina, J. J., Sánchez-Rovira, P., Bernabé, R., Bolaños, M., González, E., Belón, J., Gómez-Reina, M. J., Gallurt, P., Moreno-Nogueira, J. A.

“…Abstract only…”
Get full text

A propósito de un caso: linfoma mediastínico y cirugía by Vicente Baz, D., Calvo García, E., Moreno Nogueira, J. A.

Get full text

Non-Hodgkin's lymphomas: introduction by Moreno-Nogueira, J A, Casas, A, Iglesias Perez, L, Andrev-Kern, F

Get more information

Pain treatment in cancer patients by Moreno Nogueira, J A

Get more information

Enfermedad de Hodgkin epitroclear: Aportación de un nuevo caso by Vicente Baz, D., Ruiz Borrego, M., Arriola Arellano, E., Fernández-Freire, A., Moreno Nogueira, J. A.

Get full text

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study by MORALES, Serafin, LORENZO, Antonio, OLTRA, Amparo, FRAU, Adolfo, MACHENGS, Ignacio, GALAN, Antonio, BELON, Joaquin, LLORCA, Cristina, RAMOS, Manuel, BALLESTEROS, Pedro, MENDEZ, Miguel, ALMANZA, Concepcion, CASTELLANOS, Javier, MORENO-NOGUEIRA, José Andrés, CASAL, Joaquin, LIZON, José

“…In this multicentre phase II study, the efficacy and safety profile of the combination of docetaxel and epirubicin as first-line chemotherapy for metastatic…”
Get full text

Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group by Bezwoda, W, Rastogi, R B, Erazo Valla, A, Diaz-Maqueo, J C, Pavlovsky, S, Morioka, H, Resegotti, L, Rueckle, H, Somoza, N, Moreno-Nogueira, J A

“…59 previously untreated patients with intermediate- or high-grade, stage II-IV non-Hodgkin's lymphoma (NHL) were entered into an open-label, randomised,…”
Get full text

Hepatoblastoma in an adult by Vicente, D, Bernabé, R, Mazo, J, Moreno Nogueira, J A

Get more information

A propósito de un caso: linfoma mediastínico y cirugía by Vicente Baz, D., Calvo García, E., Moreno Nogueira, J. A.

“…PROPÓSITO: el linfoma B primario mediastínico (LBPM) es una entidad clínico-patológica diferenciada reconocida en la clasificación REAL¹. Constituye una…”
Get full text

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer by REINA, Juan José, APARICIO, Jorge, SALVADOR, Javier, PUERTO PICA, José Maria, RUEDA, Antonio, LORENZO, Antonio, GONZALEZ DE LA PUENTE, Carlos, BORREGA, Pablo, MORENO-NOGUEIRA, José Andrés

“…In this multicenter phase II study the efficacy and safety of the alternating schedule of irinotecan (CPT-11) with bolus 5-fluorouracil (5-FU) and leucovorin…”
Get full text